These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6889150)

  • 1. [Antithrombin III activity during hemodialysis].
    Rydzewski A; Soszka J; Myśliwiec M
    Pol Arch Med Wewn; 1983 Feb; 69(2):123-8. PubMed ID: 6889150
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antithrombin III in chronic renal insufficiency].
    Bekić-Kaluza S; Macanović M
    Med Arh; 1991; 45(1-2):3-8. PubMed ID: 1366314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hemodialysis and peritoneal dialysis on antithrombin III and platelets.
    Woo KT; Wei SS; Lee EJ; Lau YK; Lim CH
    Nephron; 1985; 40(1):25-8. PubMed ID: 4000334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma antithrombin III concentration in patients on regular haemodialysis treatment.
    Jørgensen M; Eriksen HO; Tranebjaerg L
    Nephron; 1985; 40(1):22-4. PubMed ID: 4000333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antithrombin III and heparinemia in patients on hemodialysis].
    Nagami AE; Sesin AM; Nattero GN
    Rev Fac Cien Med Univ Nac Cordoba; 1988; 46(1):23-6. PubMed ID: 3273332
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombin-III activity in chronic renal failure.
    Gupta V; Verma SL; Bhardwaj KL; Singh JP
    J Assoc Physicians India; 1986 Aug; 34(8):572-3. PubMed ID: 3793678
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute effects of sulodexide on the lipid profile and on antithrombin III in patients with chronic renal insufficiency in hemodialysis treatment].
    Averna MR; Citarella P; Picone F; Capodicasa G; Galione A; Rini G; Notarbartolo A
    Clin Ter; 1984 Jan; 108(2):111-4. PubMed ID: 6232045
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithrombin III in uremia.
    Jørgensen KA; Stoffersen E
    Scand J Urol Nephrol; 1979; 13(3):299-303. PubMed ID: 531528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal pathology in the Ivory Coast: exploration and functional activity of antithrombin iii].
    Blavy G; Kouame C
    Nephrologie; 1994; 15(6):387-9. PubMed ID: 7862227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.
    Toulon P; Jacquot C; Capron L; Frydman MO; Vignon D; Aiach M
    Thromb Haemost; 1987 Jun; 57(3):263-8. PubMed ID: 3660328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The resistance of activated partial thromboplastin time to heparin infusion during hemodialysis].
    Camici M; Sagripanti A; Barsotti G; Baicchi U; Evangelisti L; Morelli E; Giovannetti S
    Minerva Med; 1995 Sep; 86(9):353-5. PubMed ID: 7501225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin deficiency in end-stage renal disease associated with paraplegia: effect of hemodialysis.
    Vaziri ND; Winer RL; Alikhani S; Danviryasup K; Toohey J; Hung E; Gordon S; Eltorai I; Paule P
    Arch Phys Med Rehabil; 1985 May; 66(5):307-9. PubMed ID: 3924003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of thrombin formation during hemodialysis with triglyceride.
    Kitamoto Y; Fukui H; Matsushita K; Sato T; Soejima H; Noguchi Y; Kasama T
    ASAIO J; 1993; 39(3):M581-3. PubMed ID: 8268604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disruption of regulatory possibilities of the plasma kallikrein-kinin system in chronic kidney failure and during hemodialysis].
    Shutov EV; Dotsenko VL; Ermolenko VM; Iarovaia GA
    Vopr Med Khim; 1994; 40(1):32-5. PubMed ID: 8122407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of the thrombin-antithrombin III complex in dialysis patients during erythropoietin therapy.
    Opatrný K; Opatrná S; Vít L; Opatrný K; Bláha J; Válek A
    Nephrol Dial Transplant; 1992; 7(10):1072-3. PubMed ID: 1331891
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of serum level of antithrombin-III antigen, antithrombin activity, and its ratio of AT-III-heparin complex formation in maintenance hemodialysis patients].
    Yoshida K; Saka M; Kaneko Y; Kubota K; Hirao Y; Okajima E; Ishida M; Kihouin K; Motomiya Y
    Nihon Jinzo Gakkai Shi; 1989 Nov; 31(11):1171-7. PubMed ID: 2625740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of hemodialysis on the concentration of beta 2-microglobulin and acute phase proteins in the serum of patients with chronic renal failure].
    Starzyk J; Bartelik S; Kowalski D
    Wiad Lek; 1990 Feb 1-15; 43(3-4):114-7. PubMed ID: 1695043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
    Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin treatment may induce antithrombin-III depletion.
    Arinsoy T; Ozdemir O; Arik N; Ozcebe O; Yasavul U; Dündar S; Turgan C; Kirazli S; Cağlar S
    Nephron; 1992; 62(4):480-1. PubMed ID: 1300451
    [No Abstract]   [Full Text] [Related]  

  • 20. Impaired vessel wall response to venous occlusion in patients with chronic renal failure on maintenance hemodialysis.
    Winter M; Needham J; Mackie I; Cameron JS
    Clin Nephrol; 1984 Dec; 22(6):307-13. PubMed ID: 6441660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.